2-Metoksi-5-sülfamoilbenzoik asit ve 2-amino-5/6-pikolin tuzları ve bunların Cu(II) komplekslerinin sentezi, karakterizasyonu, anti-mikrobiyal aktivite çalışmaları

Öz

2-Metoksi-5-sülfamoilbenzoik asit (Hsba) ve 2-amino-X-pikolin {X = 5 (2a5mp) ve 6 (2a6mp)} arasında elde edilen iki yeni tuz (1 ve 2) ve bunların Cu(II) kompleksleri (3 ve 4) elde edilmiştir. Tuzların (1 ve 2) yapıları element analizi, NMR, FT-IR ve UV-Vis ile önerilirken Cu(II) komplekslerinin (3 ve 4) yapıları element analizi, AAS, UV-Vis ve manyetik duyarlılık teknikleri ile önerilmiştir. Asit:baz oranı 1 ve 2 tuzları için 1:1 iken, metal:asit:baz oranı 3 ve 4 tuzları için 1:2:2 idi. Spektroskopik analiz sonuçlarına göre 3 ve 4 bileşiklerinin yapıları şöyleydi: oktahedral olarak önerilmiştir. Ayrıca serbest ligandların, tuzların ve komplekslerin anti-mikrobiyal aktiviteleri Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (NRRL B-767), Bacillus subtilis, Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC25922) ve Listeria monocytogenes'e karşı incelenmiştir. (ATCC 7644) bakterileri ve Candida albicans (F89) mayası. Sonuçlar antibiyotiklerle (Flukonazol, Vankomisin, Sefepim ve Levofloksasin) karşılaştırıldı. Tüm bileşikler bakteri ve mayalara karşı aktivite gösterdi. Bileşiklerde C. Albicans için Cu(OAc)2.2H2O, 2 ve 4 (31,25 µg/mL), L. monocytogens için Hsba ve 3 (31,25 µg/mL), B. subtilis için 2a5mp (7,80 µg/mL), E. Coli için tüm bileşikler (Hsba ve 2 hariç) (62,50 µg/mL), S. aureus için Hsba (31,25 µg/mL), E. Faecalis için Hsba ve 1 (31,25 µg/mL) ve P. aeruginoa için 3 (15,60 µg/mL) en iyi aktiviteye sahiptir.

Anahtar Kelimeler

• 2-Aminopikolin
• 2-metoksi-5-sülfamoilbenzoik asit
• tuz
• Cu(II) kompleksleri
• anti-bakteriyel aktivite
• anti-fungal aktivite.

Synthesis, characterization, anti-microbial activity studies of 2-methoxy-5-sulfamoylbenzoic acid and 2-amino-5/6-picoline salts and their Cu(II) complexes

Abstract

Two new salts (1 and 2) obtained between 2-methoxy-5-sulfamoylbenzoic acid (Hsba) and 2-amino-X-picoline {X = 5 (2a5mp) and 6 (2a6mp)} and their Cu(II) complexes (3 and 4) have been obtained. The structures of the salts (1 and 2) were suggested by elemental analysis, NMR, FT-IR and UV-Vis, while the structures of Cu(II) complexes (3 and 4) were suggested by elemental analysis, AAS, UV-Vis and magnetic susceptibility techniques. While the acid:base ratio was 1:1 for 1 and 2 salts, the metal:acid:base ratio was 1:2:2 for 3 and 4. According to the results of spectroscopic analysis, the structures of 3 and 4 compounds were proposed as octahedral. Additionally, anti-microbial activities of free ligands, salts and complexes were studied against Pseudomonas aeruginosa (ATCC 27853), Staphylococcus aureus (NRRL B-767), Bacillus subtilis, Enterococcus faecalis (ATCC 29212), Escherichia coli (ATCC25922) and Listeria monocytogenes (ATCC 7644) bacteria and Candida albicans (F89) yeast. The results were comparisoned with the antibiotics (Fluconazole, Vancomycin, Cefepime and Levofloxacin). All compounds showed activity against bacteria and yeasts. Compounds Cu(OAc)2.2H2O, 2 and 4 (31.25 µg/mL) for C. Albicans, Hsba and 3 (31.25 µg/mL) for L. monocytogens, 2a5mp (7.80 µg/mL) for B. subtilis, all compounds (except Hsba and 2) (62.50 µg/mL) for E. Coli, Hsba (31.25 µg/mL) for S. aureus, 1 (31.25 µg/mL) for E. Faecalis and Hsba and 3 (15.60 µg/mL) for P. aeruginoa have the best activity.

Keywords

• 2-Aminopicoline
• 2-methoxy-5-sulfamoylbenzoic acid
• salt
• Cu(II) complexes
• anti-bacterial activity
• anti-fungal activity

Kaynakça

1. Perrin DD, Dempsey B and Serjeant E. pKa prediction for organic acids and bases. Springer, 1981.
2. Haynes DA, Jones W and Motherwell, WDS. Occurrence of pharmaceutically acceptable anions and cations in the Cambridge Structural Database. Journal of Pharmaceutical Sciences, 2005;94:2111-2120.
3. Berge SM, Bighley LD and Monkhouse DC. Pharmaceutical salts. Journal of Pharmaceutical Sciences, 1977;66:1-19.
4. Serajuddin AT. Salt formation to improve drug solubility. Advanced Drug Delivery Reviews, 2007;59:603-616.
5. Hamor GH and Reavlin BL. Anticonvulsants. 3. Alkyl esters of 4-bromo-2-sulfamoylbenzoic acid and 4-chloro-2-sulfamoylbenzoic acid. Journal of Pharmaceutical Sciences, 56,:134-136, 1967.
6. Scozzafava A, Owa T, Mastrolorenzo A and Supuran CT. Anticancer and antiviral sulfonamides. C Current Medicinal Chemistry, 2003;10:925-953.
7. Supuran CT, Casini A, Mastrolorenzo A and Scozzafava A. COX-2 selective inhibitors, carbonic anhydrase inhibition and anticancer properties of sulfonamides belonging to this class of pharmacological agents. Mini-Reviews in Medicinal Chemistry, 2004;4(6):625-632.
8. Choan ZH, Hassan M, Khan MK and Supuran CT. In-vitro antibacterial, antifungal and cytotoxic properties of sulfonamide-derived Schiff's bases and their metal complexes. Journal of Enzyme Inhibition and Medicinal Chemistry, 2005;20:183-188.

9. Yenikaya C, Sarı M, Bülbül M, İlkimen H, Çelik H and Büyükgüngör O. Synthesis, characterization and antiglaucoma activity of a novel proton transfer compound and a mixed-ligand Zn(II) complex. Bioorganic and Medicinal Chemistry, 2010;18(2):930-938.
10. Kumar R, Bua S, Ram S, Prete SD, Capasso C, Supuran CT and Sharma PK. Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors. Bioorganic and Medicinal Chemistry, 2017;25:1286-1293.
11. İlkimen H, Türken N and Gülbandılar A, Synthesis, characterization, antimicrobial and antifungal activity of studies of two novel aminopyridine-sulfamoylbenzoic acid salts and their Cu(II) complexes. Journal of the Iranian Chemical Society, 2021;18:1941–1946.
12. İlkimen H, Salün SG and Yenikaya C, Synthesis and characterization of metal complexes of 2-methoxy-5-sulfamoylbenzoic acid. SOCRATES 1st International Health, Engineering and Applied Sciences Congress. 19-20 June 2021, Ankara, Türkiye.
13. İlkimen H, Synthesis and characterization of mixed ligand Cu(II) complexes of 2-methoxy-5-sulfamoylbenzoic acid and 2 aminopyridine derivatives. Macedonian Journal of Chemistry and Chemical Engineering, 2019;38(1):13-17.
14. İlkimen H, Salün SG and Yenikaya C. Synthesis and characterization of Fe(III) metal complexes of sulfamoil benzoic acid derivatives. Euroasia Journal Of Mathematics-Engineering Natural & Medical Sciences, 2020;8:108-116.
15. İlkimen H, Yenikaya C and Gülbandılar A. Synthesis, characterization, investigation of antimicrobial properties of proton transfer salt and Cu(II) complex of 2-metoxy-5-sulfamoilbenzoic acid and 2,3-diaminopyridine derivatives. III. Baskent International Conference on Multidisciplinary Studies, September 23-25, 2022, Ankara, Türkiye.
16. İlkimen H, Yenikaya C and Gülbandılar A. Synthesis, characterization, and investigation of antimicrobial and antifungal activities of 2-methoxy-5-sulfamoylbenzoic acid and 2-aminonitropyridine derivatives. 3rd International Conference on Innovative Academic Studies, September 26-28, 2023, Konya, Türkiye.
17. İlkimen H and Gülbandılar A. Synthesis, characterization, and investigation of antimicrobial and antifungal activities of proton transfer salts of 2-amino-5-substitutepyridine derivatives and 2-methoxy-5-sulfamoylbenzoic acid. 2nd International Conference on Contemporary Academic Research ICCAR 2023, November 4-5 2023, Konya, Türkiye.
18. İlkimen H and Gülbandılar A. Synthesis, characterization, and investigation of antimicrobial and antifungal activities of proton transfer salts of 2-amino-6-substitutepyridine derivatives and 2-methoxy-5-sulfamoylbenzoic acid. 2nd International Conference on Contemporary Academic Research ICCAR 2023, November 4-5 2023, Konya, Türkiye.
19. Cook D, Vibrational spectra of pyridinium salts. Canadian Journal of Chemistry, 1961;39(10):2009-2023.
20. Nakamoto K. Infrared and raman spectra of inorganic and coordination compounds. 5th, Wiley-Interscience, NewYork, 1997, 232.